164 related articles for article (PubMed ID: 34452804)
1. Epidemiological investigation of spinal muscular atrophy in Japan.
Ito M; Yamauchi A; Urano M; Kato T; Matsuo M; Nakashima K; Saito K
Brain Dev; 2022 Jan; 44(1):2-16. PubMed ID: 34452804
[TBL] [Abstract][Full Text] [Related]
2. Survey of patients with spinal muscular atrophy on the island of Shikoku, Japan.
Okamoto K; Motoki T; Saito I; Urate R; Aibara K; Jogamoto T; Fukuda M; Wakamoto H; Maniwa S; Kondo Y; Toda Y; Goji A; Mori T; Soga T; Konishi Y; Nagai S; Takami Y; Tokorodani C; Nishiuchi R; Usui D; Ando R; Tada S; Yamanishi Y; Nagai M; Arakawa R; Saito K; Nishio H; Ishii E; Eguchi M
Brain Dev; 2020 Sep; 42(8):594-602. PubMed ID: 32505480
[TBL] [Abstract][Full Text] [Related]
3. Incidence of infantile spinal muscular atrophy on Shikoku Island of Japan.
Okamoto K; Fukuda M; Saito I; Urate R; Maniwa S; Usui D; Motoki T; Jogamoto T; Aibara K; Hosokawa T; Konishi Y; Arakawa R; Mori K; Ishii E; Saito K; Nishio H
Brain Dev; 2019 Jan; 41(1):36-42. PubMed ID: 30093179
[TBL] [Abstract][Full Text] [Related]
4. A multi-source approach to determine SMA incidence and research ready population.
Verhaart IEC; Robertson A; Leary R; McMacken G; König K; Kirschner J; Jones CC; Cook SF; Lochmüller H
J Neurol; 2017 Jul; 264(7):1465-1473. PubMed ID: 28634652
[TBL] [Abstract][Full Text] [Related]
5. Changes in the Incidence of Infantile Spinal Muscular Atrophy in Shikoku, Japan between 2011 and 2020.
Okamoto K; Nishio H; Motoki T; Jogamoto T; Aibara K; Kondo Y; Kawamura K; Konishi Y; Tokorodani C; Nishiuchi R; Eguchi M
Int J Neonatal Screen; 2022 Sep; 8(4):. PubMed ID: 36278622
[TBL] [Abstract][Full Text] [Related]
6. Impact of a national population-based carrier-screening program on spinal muscular atrophy births.
Aharoni S; Nevo Y; Orenstein N; Basel-Salmon L; Ben-Shachar S; Mussaffi H; Sagi-Dain L; Cohen R; Singer A
Neuromuscul Disord; 2020 Dec; 30(12):970-974. PubMed ID: 33218846
[TBL] [Abstract][Full Text] [Related]
7. [Infantile spinal atrophy: our experience in the last 25 years].
Madrid Rodríguez A; Martínez Martínez PL; Ramos Fernández JM; Urda Cardona A; Martínez Antón J
An Pediatr (Barc); 2015 Mar; 82(3):159-65. PubMed ID: 25103837
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Genotypes and Epidemiology of Spinal Muscular Atrophy in Greece: A Nationwide Study Spanning 24 Years.
Kekou K; Svingou M; Sofocleous C; Mourtzi N; Nitsa E; Konstantinidis G; Youroukos S; Skiadas K; Katsalouli M; Pons R; Papavasiliou A; Kotsalis C; Pavlou E; Evangeliou A; Katsarou E; Voudris K; Dinopoulos A; Vorgia P; Niotakis G; Diamantopoulos N; Nakou I; Koute V; Vartzelis G; Papadimas GK; Papadopoulos C; Tsivgoulis G; Traeger-Synodinos J
J Neuromuscul Dis; 2020; 7(3):247-256. PubMed ID: 32417790
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - a literature review.
Verhaart IEC; Robertson A; Wilson IJ; Aartsma-Rus A; Cameron S; Jones CC; Cook SF; Lochmüller H
Orphanet J Rare Dis; 2017 Jul; 12(1):124. PubMed ID: 28676062
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of muscular dystrophy and spinal muscular atrophy in Croatia: data from national and non-governmental organization registries.
Draušnik Ž; Cerovečki I; Štefančić V; Mihel S; Stevanović R; Barišić N; Matković H; Melša M; Mirić M; Pjevač N; Benjak T
Croat Med J; 2019 Dec; 60(6):488-493. PubMed ID: 31894913
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of morbidities across the lifespan for adults with spinal muscular atrophy: a retrospective cohort study.
G Whitney D; E Neil Knierbein E; K Daunter A
Orphanet J Rare Dis; 2023 Aug; 18(1):258. PubMed ID: 37653507
[TBL] [Abstract][Full Text] [Related]
12. Burden of Spinal Muscular Atrophy (SMA) on Patients and Caregivers in Canada.
McMillan HJ; Gerber B; Cowling T; Khuu W; Mayer M; Wu JW; Maturi B; Klein-Panneton K; Cabalteja C; Lochmüller H
J Neuromuscul Dis; 2021; 8(4):553-568. PubMed ID: 33749617
[TBL] [Abstract][Full Text] [Related]
13. The Cure SMA Membership Surveys: Highlights of Key Demographic and Clinical Characteristics of Individuals with Spinal Muscular Atrophy.
Belter L; Jarecki J; Reyna SP; Cruz R; Jones CC; Schroth M; O'Toole CM; O'Brien S; Hall SA; Johnson NB; Paradis AD
J Neuromuscul Dis; 2021; 8(1):109-123. PubMed ID: 33104036
[TBL] [Abstract][Full Text] [Related]
14. Spinal Muscular Atrophy: Diagnosis, Incidence, and Newborn Screening in Japan.
Kimizu T; Ida S; Okamoto K; Awano H; Niba ETE; Wijaya YOS; Okazaki S; Shimomura H; Lee T; Tominaga K; Nabatame S; Saito T; Hamazaki T; Sakai N; Saito K; Shintaku H; Nozu K; Takeshima Y; Iijima K; Nishio H; Shinohara M
Int J Neonatal Screen; 2021 Jul; 7(3):. PubMed ID: 34287247
[TBL] [Abstract][Full Text] [Related]
15. Mapping the differences in care for 5,000 spinal muscular atrophy patients, a survey of 24 national registries in North America, Australasia and Europe.
Bladen CL; Thompson R; Jackson JM; Garland C; Wegel C; Ambrosini A; Pisano P; Walter MC; Schreiber O; Lusakowska A; Jedrzejowska M; Kostera-Pruszczyk A; van der Pol L; Wadman RI; Gredal O; Karaduman A; Topaloglu H; Yilmaz O; Matyushenko V; Rasic VM; Kosac A; Karcagi V; Garami M; Herczegfalvi A; Monges S; Moresco A; Chertkoff L; Chamova T; Guergueltcheva V; Butoianu N; Craiu D; Korngut L; Campbell C; Haberlova J; Strenkova J; Alejandro M; Jimenez A; Ortiz GG; Enriquez GV; Rodrigues M; Roxburgh R; Dawkins H; Youngs L; Lahdetie J; Angelkova N; Saugier-Veber P; Cuisset JM; Bloetzer C; Jeannet PY; Klein A; Nascimento A; Tizzano E; Salgado D; Mercuri E; Sejersen T; Kirschner J; Rafferty K; Straub V; Bushby K; Verschuuren J; Beroud C; Lochmüller H
J Neurol; 2014 Jan; 261(1):152-63. PubMed ID: 24162038
[TBL] [Abstract][Full Text] [Related]
16. A Study on the Incidence and Prevalence of 5q Spinal Muscular Atrophy in Canada Using Multiple Data Sources.
Price TR; Hodgkinson V; Westbury G; Korngut L; Innes MA; Marshall CR; Nelson TN; Huang L; Parboosingh J; Mah JK
Can J Neurol Sci; 2024 Jan; ():1-12. PubMed ID: 38178730
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Mutation Analysis and Report of 12 Novel Mutations in a Cohort of Patients with Spinal Muscular Atrophy in Iran.
Sharifi Z; Taheri M; Fallah MS; Abiri M; Golnabi F; Bagherian H; Zeinali R; Farahzadi H; Alborji M; Tehrani PG; Amini M; Asnavandi S; Hashemi M; Forouzesh F; Zeinali S
J Mol Neurosci; 2021 Nov; 71(11):2281-2298. PubMed ID: 33481221
[TBL] [Abstract][Full Text] [Related]
18. Spinal muscular atrophy.
D'Amico A; Mercuri E; Tiziano FD; Bertini E
Orphanet J Rare Dis; 2011 Nov; 6():71. PubMed ID: 22047105
[TBL] [Abstract][Full Text] [Related]
19. Opportunities for an early recognition of spinal muscular atrophy in primary care: a nationwide, population-based, study in Italy.
Maggi L; Vita G; Marconi E; Taddeo D; Davì M; Lovato V; Cricelli C; Lapi F
Fam Pract; 2023 Mar; 40(2):308-313. PubMed ID: 35950319
[TBL] [Abstract][Full Text] [Related]
20. Patient Reported Impact of Symptoms in Spinal Muscular Atrophy (PRISM-SMA).
Mongiovi P; Dilek N; Garland C; Hunter M; Kissel JT; Luebbe E; McDermott MP; Johnson N; Heatwole C
Neurology; 2018 Sep; 91(13):e1206-e1214. PubMed ID: 30143566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
